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he integrin 
 
 
 
3
 
 
 
1 mediates cellular adhesion to the
matrix ligand laminin-5. A second integrin ligand,
the urokinase receptor (uPAR), associates with 
 
 
 
3
 
 
 
1
via a surface loop within the 
 
 
 
3 
 
 
 
-propeller (residues 242–
246) but outside the laminin binding region, suggesting
that uPAR–integrin interactions could signal differently
from matrix engagement. To explore this, 
 
 
 
3
 
 
 
/
 
 
 
 epithelial
cells were reconstituted with wild-type (wt) 
 
 
 
3 or 
 
 
 
3 with
Ala mutations within the uPAR-interacting loop (H245A or
R244A). Wt or mutant-bearing cells showed comparable
expression and adhesion to laminin-5. Cells expressing wt
T
 
 
 
3 and uPAR dissociated in culture, with increased Src
activity, up-regulation of SLUG, and down-regulation of
 
E-cadherin and 
 
 
 
-catenin. Src kinase inhibition or expression
of Src 1–251 restored the epithelial phenotype. The H245A
and R244A mutants were unaffected by coexpression of
uPAR. We conclude that 
 
 
 
3
 
 
 
1 regulates both cell–cell
contact and matrix adhesion, but through distinct protein
interaction sites within its 
 
 
 
-propeller. These studies reveal
an integrin- and Src-dependent pathway for SLUG expression
and mesenchymal transition.
 
Introduction
 
The integrin 
 
 
 
3
 
 
 
1 is highly expressed in epithelial cells
and associated with invasiveness of malignant carcinomas
(Morini et al., 2000). The major endogenous ligand for
 
 
 
3
 
 
 
1 has proven to be laminin-5 (Eble et al., 1998). The
binding of laminin-5 to 
 
 
 
3
 
 
 
1 is non-RGD dependent but,
like RGD ligands, involves the upper surface of the integrin 
 
 
 
chain 
 
 
 
-propeller. Mutation of glycine 163, located within
an upper surface loop between blades 2 and 3 of the propel-
ler (highlighted as green in Fig. 1), completely abrogates lami-
nin-5 interaction with 
 
 
 
3
 
 
 
1 (Zhang et al., 1999).
In spite of its typical matrix binding capacity, among 
 
 
 
1
integrins, 
 
 
 
3
 
 
 
1 has unusual and distinctive features. This
integrin does not localize to focal adhesion sites only (Dogic
et al., 1998), but instead is frequently also found in or near
epithelial adherens junctions (Nakamura et al., 1995).
Newborn mice lacking 
 
 
 
3
 
 
 
1 have disordered adherens
junction formation in kidney epithelial cells (Wang et al.,
1999). 
 
 
 
3
 
 
 
1 has also been reported to associate tightly and
specifically with the tetraspan protein CD151 (Berditchevski
et al., 2001).
Although there is currently no mechanism linking 
 
 
 
3
 
 
 
1
expression and E-cadherin function, there is evidence that
integrins influence E-cadherin. In mammary epithelial cells,
 
 
 
1 integrin signaling promoted formation of adherens
junctions with relocalization of E-cadherin to the lateral side
of cells. Conversely, in colon carcinoma cells, overexpression
of active Src leads to redistribution of E-cadherin away from
adherens junctions. As judged by antibodies to either 
 
 
 
v or
 
 
 
1, the Src responses required integrin signaling (Avizienyte
et al., 2002). As mentioned, kidney epithelial cells deficient
in 
 
 
 
3
 
 
 
1 show loss of normal E-cadherin junctions (Wang et
al., 1999). Together these data are consistent with the view
that matrix–integrin associations regulate epithelial cell–cell
interactions involving E-cadherin, and that in some way this
cross-talk likely involves Src activation through integrins.
We recently reported that the urokinase receptor (uPAR),
a glycosylphosphorylinositol (GPI)-linked surface protein,
preferentially and physically associates with 
 
 
 
3
 
 
 
1 (Wei et al.,
2001). uPAR, by virtue of its ability to initiate a proteolytic
cascade and its capacity to modify integrin function, is also
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implicated in cell migration (Blasi and Carmeliet, 2002).
Numerous studies document the independent poor predic-
tive value of uPAR expression on tumor metastasis (Yang et
al., 2000). Several recent reports attest to the ability of
uPAR to influence cell migration independently of uroki-
nase protease activity (Ossowski and Aguirre-Ghiso, 2000).
One such mechanism appears to be the ability of uPAR to
influence integrin function, either by direct binding or
through signaling. Based on sequence homology to a previ-
ously described uPAR-binding phage display peptide, we
identified and provided evidence for an interaction site for
uPAR within the repeat 4 BC loop of 
 
 
 
M (CD11b), a 
 
 
 
2-
associating 
 
 
 
 chain (Simon et al., 2000). Among integrin 
 
 
 
chains associating with 
 
 
 
1 integrins, the homologous loop
of 
 
 
 
3 has the closest sequence homology to uPAR-binding
site of 
 
 
 
M (highlighted in Fig. 1 B). Unlike the association
of CD151 with 
 
 
 
3
 
 
 
1, the physical interaction of uPAR
with this integrin is not constitutive. Binding of purified,
soluble uPAR with purified soluble 
 
 
 
3
 
 
 
1 is strongly pro-
moted by concurrent binding of urokinase to uPAR and by
agents that activate integrins (Wei et al., 2001). Similar
patterns have been reported for uPAR–integrin interac-
tions by several groups (Carriero et al., 1999; Tarui et al.,
2001). Thus, the interaction of uPAR with 
 
 
 
3
 
 
 
1 appears
to be dynamic and influenced by multiple factors that af-
fect the conformation of each interacting partner, typical
for integrin ligands.
To probe further the interaction between uPAR and
 
 
 
3
 
 
 
1, we generated point mutants of the most conserved
amino acids within the repeat 4 BC loop of the integrin 
 
 
 
chains reported to interact with uPAR and expressed them
in an 
 
 
 
3-null background. Analysis of multiple clones of
mutant and wild-type (wt) 
 
 
 
3– and uPAR-expressing cells
confirms the fourth repeat BC loop as an important interac-
tion site for uPAR and reveals a mechanism linking 
 
 
 
3
 
 
 
1
and E-cadherin.
 
Results
 
Selection and expression of integrin mutants
 
Recently reported studies of the crystal structure of 
 
 
 
v
 
 
 
3
confirm the earlier proposal that the NH
 
2
 
-terminal region
(
 
 
 
450 residues) of integrin 
 
 
 
 chains folds into a seven-
bladed 
 
 
 
-propeller (Springer, 1997; Xiong et al., 2001).
Schematics of the NH
 
2
 
-terminal regions of 
 
 
 
3
 
 
 
1, modeled
on the atomic coordinates of 
 
 
 
v
 
 
 
3 (using Modeller v4.0),
showing the numbered blades are illustrated in Fig. 1. Be-
cause His 245 is conserved among the three integrin 
 
 
 
chains showing the most robust interaction with uPAR in
coprecipitation studies (Fig. 1 B), and is contained in the
original phage peptide used to block integrin–uPAR associa-
tion, we first mutated this His to Ala. In subsequent experi-
ments, we also mutated the adjacent Arg 244 to Ala. Similar
point mutations of several additional mutations in this re-
gion, including Gly, Val, and Arg, were found to be either
weakly expressed or not expressed at all. These mutants were
not further pursued. In addition, we expressed a Gly 163 to
Ala mutation in 
 
 
 
3 (Fig. 1). This point mutant has previ-
ously been reported by Zhang et al. (1999) to be expressible
and yet exhibit no binding to laminin-5 when expressed in
K562 cells. Inspection of the top view of the modeled 
 
 
 
3
 
 
 
1
indicates that G163 is accessible on the 
 
 
 
-propeller up-
per surface, consistent with its role in laminin-5 binding,
whereas H245 is not. Both G163 and H245 are on loops
predicted to be accessible via the lateral surface.
The wt, H245A, and G163A integrin 
 
 
 
 chains were sta-
bly expressed in a murine 
 
 
 
3-null kidney epithelial cell line
(Fig. 2 A). Multiple clones of each expression construct
were isolated and frozen for subsequent experiments. To
examine their matrix-binding function, the various inte-
grin-expressing cells were tested for their capacity to adhere
to purified laminin-5. The 
 
 
 
3-null cells showed very weak
attachment to laminin-5. The photograph in Fig. 2 B
Figure 1. Model of  3  -propeller structure. (A) Top and side views of the predicted  -propeller structure of the  3 chain (blue) and the 
NH2-terminal part of its associated  1 chain (gray) modeled on the crystal structure of integrin  v 3 (Xiong et al., 2001). The positioning of 
Gly163 and His245 in the  -propeller are indicated in green and red, respectively. (B) A schematic of the integrin  3 chain showing sequence 
homologies between the reported  3 interaction site with uPAR (repeat 4 BC loop of the  -propeller structure) and  M as well as other 
 1-integrin–coupled   chains. Three mutations (*) were made in repeat 2 or repeat 4 of the  3  -propeller region, as indicated in the figure.T
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highlights robust adhesion of both wt and H245A inte-
grins to 0.5  g/ml of laminin-5. Both wt  3 and the
H245A mutant adhered indistinguishably to all coating
concentrations of laminin-5 tested (0.1–10  g/ml) (Fig. 2
C). Strong adhesion of the H245A mutant was not unex-
pected, as the repeat 4 BC loop of integrins has not been
implicated directly in matrix ligand engagement. Also as
expected, cells bearing the G163A  3 mutant did not
attach to laminin-5. Adhesion to laminin-5 by cells ex-
pressing either wt or the H245A mutant integrin was ac-
companied by transient FAK activation (Fig. 2 D). FAK
activation initiated by either the wt or the H245A mutant
integrin was identical, increasing within minutes of plating
and returning to baseline by 16 h.
Integrins affect cell–cell contact: influence of uPAR
We next compared the morphology and cytoskeletal organi-
zation of cells expressing either wt or repeat 3 (G163A) or
repeat 4 (H245A) mutants. Cells expressing wt  3 (R10
cells) illustrated a classical epithelial cell morphology in
two-dimensional culture with clustering and formation of
extensive cell–cell borders. This pattern was seen when cells
were plated onto either serum- or laminin-5–coated surfaces
(Fig. 3, A and B). The G163A mutant formed even more
compact cell clusters, showing little tendency to spread ei-
ther on vitronectin, fibronectin, or laminin-5 (not de-
picted). Although the H245A mutant formed clear cell–cell
borders and clusters of epithelial cells, these clusters ap-
peared somewhat less compact than those of R10 or G163A
cells (Fig. 3, A and B).
Morphological differences among the cell lines became
more apparent upon transfection with uPAR. Epithelial
cells coexpressing uPAR and wt  3 (R10/U) dissociate in
culture and fail to form extensive cell–cell borders or clus-
ters (Fig. 3 A). These findings were observed in at least
five distinct clones of uPAR/wt  3–coexpressing cells and
were critically dependent upon expression of both pro-
teins. Periodic loss of expression of either  3 or uPAR
upon passaging for months led to a reversion to the phe-
notype of  3-null or uPAR minus  3–bearing cells, re-
spectively. Plating of cells on laminin-5 to ensure engage-
ment of surface  3 1 also led to stable clusters and did
not block the dissociative effect of concurrent uPAR ex-
pression (Fig. 3 B). In contrast to the striking phenotypic
effect of uPAR overexpression on wt  3 cells, expression
of uPAR had no discernible effect on cells expressing the
H245A mutant. Again, multiple clones were examined,
and no H245A  3 clone showed a morphological response
to uPAR expression.
These morphological differences were reflected in altered
motility as judged by 18-h time-lapse microscopy. Wt  3
cells coexpressing uPAR showed marked enhancement of
random motility over that of cells coexpressing H245A  3
and uPAR (Fig. 3 C), with little tendency after cell division
or contact to form stable cell–cell clusters. The H245A  3
cells coexpressing uPAR formed the clusters seen in Fig. 3 A
largely by replication of cells within smaller two- to four-cell
clusters, consistent with their largely stationary state during
the observation period (Fig. 3 C; Videos 1 and 2, available at
http://www.jcb.org/cgi/content/full/jcb.200304065/DC1).
Figure 2. Kidney epithelial cells 
expressing either wt  3 or the H245A 
mutant adhere to laminin-5. (A) FACS
® 
analysis of wt (R10) and mutant  3 
(H245A) expression on  3-null cells 
(B12). R10, H245A, or G163A  3 
integrins were stably expressed in B12 
cells and visualized by staining with 
P1B5. (B) Adhesion to laminin-5. Cells 
were seeded on laminin-5 (0.5  g/ml) 
for 1 h at 37 C, washed, fixed, and 
stained with Giemsa. A representative 
of three independent experiments with 
triplicate wells is shown. (C) R10 and 
H245A cells adhere identically to 
laminin-5. A 96-well tissue culture 
plate was precoated with laminin-5 
(0.1–10  g/ml) and then blocked in 1% 
BSA. Adhesion was assayed as described 
in B. Data are expressed as mean   SD 
of triplicate wells (n   3). (D) FAK 
phosphorylation induced by laminin-5 
engagement.  3-null (B12) or wt (R10) 
or H245A mutant  3–expressing cells 
were serum starved for 4 h and exposed 
to the immobilized laminin-5. Cells were 
lysed in RIPA buffer and immunoblotted 
for phospho-FAK and total FAK at various 
times as indicated. Data are expressed as 
ratio of phospho-FAK/total FAK. The ratio 
at time 0 for each cell line was made 1. 
This experiment was repeated three 
times with similar results.T
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To test whether these observations were unique to the
H245A mutant, the adjacent Arg 244 was also point mutated
to Ala (Fig. 1 B). This mutant, like the H245A mutant, was
expressible and showed normal adhesion to laminin-5 (unpub-
lished data). Coexpression of uPAR in these cells also failed to
influence cell–cell border formation or organization in culture,
consistent with the response of the H245A mutant to uPAR
expression. Expression of uPAR in cells bearing the G163A in-
tegrin mutant also failed to show morphological changes; the
cells maintained a tightly clustered phenotype (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200304065/
DC1). Because of the striking differences between the pheno-
types of wt and mutant  3 responses to coexpression of uPAR,
we focused on the physical and molecular connections be-
tween  3 1 and uPAR that could explain these responses.
The H245A mutation impairs uPAR–integrin 
complex formation
We have previously reported that recombinant soluble uPAR
binds to immobilized peptides containing the exposed blade
4 BC loop (residues 242–246) of  3 (Wei et al., 2001). This
assay was used to test whether the single H245A mutation
was likely to affect the direct interaction of uPAR with  3. As
indicated in Fig. 4 B, soluble uPAR binding to immobilized
 3 residues 241–257 ( 325) was progressively blocked by
the addition of soluble  325 (1–50  M), whereas addition
of either scrambled  325 (sc 325) or  325 containing the
H245A mutation ( 325HA) did not compete at any concen-
tration tested, indicating that the H245A mutation could ef-
fect direct uPAR– 3 interaction. Although not shown, pep-
tide 241–257 containing the R244A mutation also failed to
compete at up to 100  M. The capacity of uPAR to complex
with native integrin was assessed first by coprecipitation of wt
and H245A mutant  3 integrins with uPAR antibodies. Wt
 3 was easily found in the uPAR immunoprecipitates (Fig. 4
C). In contrast to wt  3 coprecipitation with uPAR, little or
no H245A  3 was seen in parallel immunoprecipitations of
uPAR. This pattern was consistently found among two dif-
ferent uPAR/mutant integrin clones and in four separate im-
munoprecipitations. In these experiments, both the integrins
and uPAR were comparably expressed as judged by FACS
®
(Fig. 4 A) and immunoblotting of cell lysates (Fig. 4 C). In
parallel experiments, the capacity of either the R244A mu-
tant or the G163A mutant to coprecipitate with uPAR was
also examined. Results were similar to those shown for
H245A; neither mutant integrin coprecipitated well with
uPAR (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200304065/DC1).
Figure 3. Expression of uPAR alters cell–cell contact and cytoskeleton organization. (A and B) Cells expressing wt or H245A  3 form 
clusters with extensive cell–cell contact when cultured either in 10% serum (A) or serum-free on purified laminin-5 (B). After uPAR transfection, 
wt  3–bearing cells scatter (Video 1, available at http://www.jcb.org/cgi/content/full/jcb.200304065/DC1), whereas cells expressing the H245A 
are unaffected (Video 2). Nearly identical changes in cellular morphology after uPAR transfection were seen with serum- or laminin-5–coated 
surfaces. (C) Cells expressing both uPAR and wt  3 are motile. R10, H245A, R10/U, or H245/U cells were maintained in a heated chamber, 
and images were collected every 10 min using a time-lapse imaging system (Spot Camera). Tracking of individual cells was done using 
SimplePCI software. Data (mean   SD) of cell distance ( m) moved and speed are based on 18 cells in each movie tracked.T
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Coprecipitation of uPAR and  3 1 was also observed
when antibodies to  3 were used (Fig. 4 D). Again, no uPAR
was seen when  3 antibodies were used to precipitate the
H245A mutant, even though equivalent amounts of  3 were
recovered. To probe further the complex formation between
uPAR and  3 1, antibodies to CD151 were also used to pre-
cipitate  3, and then those precipitates were examined for
the presence of uPAR. CD151 is known to constitutively as-
sociate with  3 1, and its site of interaction has been re-
cently localized to the “stalk” region (residues 538–673) of
the integrin  3 1 (Yauch et al., 2000). As uPAR interacts
with the integrin  -propeller, both proteins could conceiv-
ably be found in the CD151 immunoprecipitations. Indeed,
uPAR was observed coprecipitating with CD151 (Fig. 4 D),
but this was critically dependent on the integrin sequence be-
cause no uPAR was seen in the CD151 immunoprecipitation
of H245A  3 cells even though comparable amounts of  3
were recovered. The amounts of  3 coprecipitating with
CD151 were markedly less than that precipitated with  3
antibodies, possibly because the CD151 antibody (5C11)
was originally raised in mice against human CD151. This
difference could also reflect relatively high levels of  3 in
excess over CD151 in these reconstituted cells. Because
no blotting antibody for murine CD151 exists to resolve
this uncertainty, we also examined human cells expressing
CD151,  3, and uPAR (Fig. 4 D, uPAR/293 cells). Again,
precipitation of CD151 coprecipitated both  3 and uPAR.
These data confirm that CD151, uPAR, and  3 1 form a
multimeric complex. Collectively, these experiments provide
a clear biochemical correlate to the morphological response
to uPAR expression (Fig. 3); only cells bearing an  3 capable
of a strong physical association with uPAR respond to uPAR
with loss of stable cell–cell contacts and enhanced motility.
uPAR overexpression leads to an integrin-dependent 
loss of E-cadherin at cell–cell borders
The marked dissociation in culture of epithelial cells express-
ing uPAR and wt  3 suggested dysfunction of cell–cell con-
tact sites in these cells. This was assessed initially by E-cad-
herin immunostaining (Fig. 5 A). Expression of high levels
of uPAR led to a nearly complete loss of the normal E-cad-
herin staining along cell–cell borders. Instead, there was less
overall E-cadherin staining, and the staining was more dif-
fuse. Strikingly, the H245A mutant showed no discernible
change in E-cadherin distribution in the presence of high
levels of uPAR, the cells still showing extensive E-cadherin
along cell borders (Fig. 5 A).
The differences in patterns of E-cadherin immunostaining
were mirrored by changes in formation of stable E-cad-
herin– -actin complexes (Fig. 5 B). Immunoblots of the cy-
toskeletal fractions of wt and H245A  3–bearing cells
showed comparable E-cadherin,  -catenin (plakoglobin),
and   -catenin in association with actin. Expression of
uPAR, however, led to a marked reduction in actin-associ-
ated E-cadherin and  -catenin in wt  3–expressing cells. No
change in actin-associated  -catenin was found. In contrast,
there was no reduction in actin-associated E-cadherin in
H245A/U cells. Together with the coprecipitation and im-
munostaining data, these findings indicate that the single
change of His245 to Ala, or Arg244 to Ala, within the repeat
4 BC  3 loop almost completely abrogates the physical and
functional effects of uPAR on  3 1.
uPAR overexpression leads to a mesenchymal transition 
of kidney epithelial cells expressing  3/ 1
The immunoblot illustrated in Fig. 5 B suggests that total
E-cadherin and  -catenin are lower in cells coexpressing uPAR
and wt  3 1. To explore this point further, mRNA pools
Figure 4. The H245A mutation blocks  3 coimmunoprecipitation 
with uPAR. (A) FACS
® analysis of uPAR transfectants. uPAR-transfected 
 3-null (B12/U) and wt  3– and H245A mutant  3–expressing 
cells (R10/U and H245A/U) were stained with uPAR antibody R2. 
(B) Binding of biotin-suPAR to immobilized peptide  325. Biotinylated 
suPAR (50 nM) preincubated without or with peptide  325 ( ), 
sc 325( ), or  325HA ( ) (1–50  M) was added to microtiter wells 
coated with  325 (100  g/ml). Binding of suPAR in the presence 
of peptides is expressed as percentage of suPAR binding in the 
absence of peptides (% control). Values represent averages of triplicate 
determinations of three separate experiments. (C) Coimmunoprecip-
itation of uPAR and integrin  3. Human uPAR stably transfected 
into  3-null cells (B12) or cells coexpressing wt (R10) or the H245A 
mutant were lysed in 1% Triton X-100 lysis buffer, and the lysates 
were immunoprecipitated with uPAR antibody (R2). The cell lysates 
used and the immunoprecipitates were then separated by SDS-PAGE 
and blotted for integrin  3 using a polyclonal antibody (D23). 
The same membrane was stripped and reblotted for uPAR (R2). 
Data shown are representative of four independent experiments. 
(D) R10/U or H245A/U cells were lysed in 1% Triton X-100 buffer 
and immunoprecipitated with antibodies to  3 (P1B5) or CD151 
(5C11). The lysates and immunoprecipitates were then blotted for 
 3 (D23) and uPAR (R2). Data shown is a representative of three 
separate experiments with similar results. UPAR/293 cells were 
used as a control.T
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from triplicate cultures of cells expressing uPAR and either
no  3, wt  3, or the H245A mutant were transcriptionally
profiled by Affymetrix microarrays. This revealed a set of
genes whose average transcript levels were significantly differ-
ent only in cells coexpressing both uPAR and wt  3, no
change being observed in mRNA from either  3-null or
H245A-bearing cells coexpressing uPAR (not depicted). Be-
cause many of these genes are known to be associated with
mesenchymal transition of epithelial cells, consistent with the
observed phenotype (Fig. 3), primers for these genes were
constructed for real-time PCR and transcript profiling was
repeated several times (Table I). Inspection of Table I reveals
down-regulation of steady-state mRNA of both E-cadherin
and  -catenin, consistent with immunoblotting (Fig. 5). In
addition, there was selective up-regulation of syndecan II (fi-
broglycan), smooth muscle cell   actin, and the transcrip-
tional factor SLUG. All of these proteins have been im-
plicated in cellular migration and mesenchymal transition
(Yang and Liu, 2001; Park et al., 2002; Bolos et al., 2003).
SLUG is of particular interest because expression of this tran-
scriptional factor is reported to be associated with suppres-
sion of E-cadherin and desmosomal protein mRNA and pro-
motion of a mesenchymal transition in epithelial cells. The
increase in SLUG mRNA ( 15-fold) was not seen in either
the  3-negative cells or cells bearing the H245A integrin mu-
tant and uPAR. These findings suggest that acquisition of
Figure 5. Altered E-cadherin distribution and loss of E-cadherin from the cytoskeleton in epithelial cells coexpressing  3 and uPAR. 
(A) Immunostaining of E-cadherin. Cells plated on chambered glass slides were fixed, permeabilized, and stained for E-cadherin as described 
in the text. (B) Immunoblotting of total and actin-associated E-cadherin,  -catenin, and  -catenin. Triton-insoluble fractions and total lysates 
were separated by SDS-PAGE and blotted for E-cadherin,  -catenin, and  -catenin.  -Actin (Sigma-Aldrich) was used as a loading control. 
The experiments above were performed at least three times with similar results.
Table I. Quantitative PCR analysis of uPAR expression–induced integrin-dependent mRNA changes
Gene name Copy number Ratio
R10/U R10 R10/U over R10
Syndecan II 8918.97 3554.40 2.51
VEGFc 2198.58 265.29 8.29
Smooth muscle actin   10634.24 287.40 37.00
Fibroblast-specific protein 1 19440.57 19773.00 0.98
SLUG 3550.15 230.82 15.38
E-cadherin 2281.92 6671.68 0.34
 -catenin 11937.22 14182.87 0.84
 -catenin (plakoglobin) 5812.04 15840.38 0.37
GAPDH 232273.68 232273.68 1.00
Total RNA from wt  3 integrin–bearing cells without uPAR (R10) or with uPAR (R10/U) was analyzed by Taqman quantitative PCR. Transcriptional levels
were compared and expressed as a ratio. Data represent the average of triplicate determinations from a representative of three independent experiments with
similar profile.T
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SLUG expression in this cell system is due to uPAR overex-
pression, but induction requires coexpression of wt  3 1. A
marked up-regulation in VEGFc (Shushanov et al., 2000),
but not VEGFa or VEGFb, was also noted (Table I).
Although uPAR expression led to integrin-dependent
changes typical of a mesenchymal transition, there was no
change in vimentin mRNA and no induction of fibroblast-
specific protein 1. Both of these proteins are reported to be
expressed in kidney epithelial cells undergoing mesenchy-
mal transformation in response to transforming growth fac-
tors, indicating that uPAR expression alone is not sufficient
to drive frank mesenchymal transformation (Strutz et al.,
2002). Because of the central role of the SLUG family of
transcription factors in mesenchymal development, we fo-
cused on a signaling pathway that could plausibly connect
uPAR,  3 1, and SLUG in these epithelial cells.
uPAR expression leads to Src activation: Src kinase 
inhibitors restore epithelial phenotype and reverse 
mesenchymal transition
Currently, there is limited information available regarding
signaling pathways in epithelial cells that regulate SLUG
mRNA levels. To explore a molecular pathway by which
uPAR expression could up-regulate SLUG expression and
influence adherens junction stability, cells expressing uPAR
and wt  3 were exposed to various inhibitors of second mes-
senger pathways known to be activated by integrin signaling.
Cells exposed to inhibitors of Rho family GTPases (exoen-
zyme C3, 1 ng/ml), MAP kinases (MEK [PD 98059, 10
 M], p38 kinase [SB 202190, 10  M], c-Jun NH2-terminal
kinase [JNK inhibitor, 10  M]), PI3K (wortmanin, 100
nM), serine/threonine kinases (H7, 100 nM; bisindolylma-
leimide I, 100 nM; PKC pseudosubstrate [19–31], 100
 M), or the epidermal growth factor receptor (AG1478, 1
 M) maintained a dissociated phenotype with weak or no
cell–cell border formation (unpublished data). Similarly, a
broad-spectrum matrix metalloproteinase (MMP) inhibitor
GM6001 (100 nM) did not change the phenotype, indicat-
ing that MMP activity did not account for the loss of E-cad-
herin from R10/U cells (Ho et al., 2001). In contrast, a spe-
cific inhibitor of Src family kinases, PP2 (1  M), was found
to completely reverse the dissociation of these epithelial cells
in culture (Fig. 6 A). Reversion to the epithelial phenotype
after addition of PP2 was not immediate but instead was
Figure 6. Integrin- and uPAR-dependent mesenchymal transition of epithelial cells is Src kinase dependent. (A) Src kinase inhibitor PP2 
restores epithelial phenotype. R10 cells expressing uPAR (R10/U) incubated with 1  M of PP2 or control PP3 in serum-free medium for 5 d 
show complete reversal of the scattering phenotype seen in Fig. 3. (B) Src kinase assay. Cells expressing wt (R10) or mutant (H245A)  3, or 
coexpressing uPAR (R10/U and H245A/U) with or without PP2 treatment, were lysed in RIPA buffer and immunoprecipitated using a pan-Src 
antibody (Src2). Src kinase activity in the precipitates was quantified by incorporation of [ -
32P]ATP into a Src substrate peptide as described 
in the Materials and methods. Activity was expressed as pmol phosphate incorporated into the substrate peptide/min. In four independent 
experiments, uPAR expression increased PP2-sensitive Src activity in cells expressing wt  3 (R10/U) but not mutant  3 (H245A/U). (C) Increased 
phosphorylation of Src substrates cortactin and caveolin but not p130Cas or FAK in R10/uPAR cells. P130Cas or cortactin was immunopre-
cipitated with a specific mAb and immunoblotted with antiphosphotyrosine pAb for phospho-p130Cas or cortactin, and the membrane was 
stripped and reblotted with a specific pAb for total p130Cas or cortactin. Phospho-FAK and total FAK were detected from lysates by 
anti–phospho-FAK and FAK mAbs, respectively. For immunoprecipitation with antiphosphotyrosine 4G10, cells were incubated with or 
without PP2 or PP3 (5  M) for 2 h at 37 C before lysis. The total phosphoproteins pulled down with 4G10 were similar among each lane 
by Ponceau S staining of the blotting membrane. The immunoprecipitates were then blotted for phosphotyrosine using a pAb or caveolin-1. 
All these experiments have been repeated at least three times with similar results.T
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only apparent after 3–4 d. By 5 d, the cells were again clus-
tered with extensive E-cadherin–rich cell–cell borders (Fig. 6
A). PP3, a structurally similar but inactive version of PP2,
had no effect on cell clustering. A second structurally dis-
tinct Src kinase inhibitor, SU6656 (1  M), also completely
restored the clustered phenotype in a similar time course
(not depicted).
Because of the striking effects of Src kinase inhibitors on
the epithelial phenotype of uPAR/integrin-expressing cells,
Src kinase activity was measured in lysates of wt and H245A
mutant–expressing cells without or with concurrent uPAR
expression. In three separate experiments, Src kinase activity
was found to be higher in R10/uPAR as compared with R10
cells, the increased activity being completely inhibited by 1
 M PP2 (Fig. 6 B). Although there was some phosphoryla-
tion of the Src substrate peptide in H245A-expressing cells
(Fig. 6 B), this kinase activity was not Src related, as it was
not inhibited by PP2. This kinase activity was also unaf-
fected by coexpression of uPAR. We next searched for Src
substrates differentially phosphorylated between R10 and
R10/U cells in culture. Initial analysis of tyrosine-phosphor-
ylated (p-tyr) proteins after immunoprecipitation with
4G10 antibodies to p-tyr showed that almost all of the dis-
cernible proteins were equally phosphorylated among cells
expressing wt or mutant integrins in the absence or presence
of uPAR (Fig. 6 C). Whereas transient activation of FAK
was apparent within minutes of plating any of the cells on
laminin-5 (Fig. 2 D), there were no differences in constitu-
tive levels of phospho-FAK among the various cells. Serum
starvation led to markedly lower tyrosine phosphorylation of
many proteins, but again, there were few differences be-
tween wt  3 1–bearing cells   uPAR. Data in Fig. 6 C
show comparable FAK and p130CAS phosphorylation be-
tween R10 and R10/U cells. However, two known Src ki-
nase substrates were identified with consistently higher
phosphorylation states in wt  3 1 cells expressing uPAR:
cortactin and caveolin-1. Enhanced cortactin and caveolin-1
phosphorylation was only observed in wt  3 1 cells coex-
pressing uPAR, the H245A/U cells showing no difference
for either protein. These data validate the Src kinase assays
of cell lysates (Fig. 6 B) and suggest that Src is likely locally
activated and to a very limited degree. Prior studies have lo-
calized uPAR with  1 integrins, cortactin, caveolin-1, and
Src-family kinases, possibly providing a spatial correlate to
the observed pattern of altered tyrosine phosphorylation
(Wei et al., 1999).
Figure 7. Src activity is required for the up-regulation of SLUG and down-regulation of E-cadherin and  -catenin in R10/uPAR cells. 
(A) Time course of PP2 reversal of increased SLUG mRNA in R10/uPAR cells. R10/U cells were incubated with PP2 (1  M) for various times 
(1–6 d), and SLUG mRNA was quantified by Taqman real-time PCR. (B) PP2 reversal of mesenchymal mRNAs expressed in epithelial cells 
by uPAR transfection. After 4 d incubation with PP2 (1  M), mRNAs for the indicated transcripts were quantified by PCR, and relative copy 
numbers were expressed as percent change from baseline R10/uPAR cells. Results shown represent a mean (  SD) of three independent 
experiments. (C) Dominant-negative Src (DnSrc) reverses scattering phenotype of R10 cells expressing uPAR. R10/U cells were transfected 
with DnSrc–GFP or GFP alone, and the sorted green cells were cultured for 4 d. The data shown is a representative from three independent 
transfections with similar results. (D) Dominant-negative Src suppresses SLUG mRNA in R10/U cells. 1 or 4 d after transfection, cells expressing 
DnSrc–GFP or GFP alone were sorted by green fluorescence, and SLUG transcription was quantified by Taqman real-time PCR.T
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To determine if enhanced Src activity was related to the
observed increased SLUG mRNA levels (Table I), SLUG
mRNA was quantified at various times after exposing cells to
PP2. Increased SLUG mRNA in R10/U cells began to de-
crease by 24 h, and by 72 h, it was virtually at basal levels of
R10 cells (Fig. 7 A). This time course corresponded to the
reversion of morphological changes to that of the parent epi-
thelial cells (Fig. 6 A). Further, E-cadherin,  -catenin, and
 -catenin mRNAs were quantified after PP2 exposure. The
mRNA levels of both E-cadherin and  -catenin also re-
turned to baseline copy numbers of R10 cells within 4 d,
whereas  -catenin changed minimally (Fig. 7 B). This corre-
sponded to increased amounts of actin-associated E-cad-
herin and  -catenin protein (not depicted), consistent with
the observed reversion to epithelial organization.
To examine the relationship between Src and SLUG with
an independent method, the capacity of Src to regulate epi-
thelial cell clustering and SLUG levels was examined by
transient transfection of wt  3 1– and uPAR-expressing
cells with a cDNA encoding a dominant-negative Src pro-
tein (DnSrc–GFP, 1–251). Because the efficiency of trans-
fection is relatively low in these cells, DnSrc–GFP was ex-
pressed, and cells expressing GFP were recovered by cell
sorting. These cells, or cells transfected with GFP alone,
were examined immediately for SLUG mRNA by quantita-
tive PCR or plated to observed their phenotype in culture.
Plating of mock-transfected cells (GFP only) resulted in a
typical R10/U phenotype (compare Fig. 7 C with Fig. 6 A).
In contrast, cells expressing detectable levels of DnSrc
showed striking cluster formation (Fig. 7 C). The fraction of
total cells clustered after 3–4 d was at least 80%, the clus-
tered phenotype being observed in each of three separate ex-
periments. When the GFP-expressing cells were recovered
and examined immediately for SLUG mRNA levels, the lev-
els in DnSrc–GFP-expressing cells were found to be reduced
 25% (1 d after transfection) and  80% (4 d after trans-
fection) as compared with GFP-transfected cells (Fig. 7 D).
These data extend earlier experiments with PP2 and indicate
that Src kinase activity and its location are critical regulators
of SLUG levels in these epithelial cells.
Discussion
Our observations are of interest for several reasons. First, the
data indicate that one origin of the capacity for integrins to
mediate both matrix engagement and cross-talk with other
adhesion pathways arises from the integrin  -propeller itself,
implying that these signaling pathways can diverge at the cell
surface. Most current thinking about integrin cross-talk fo-
cuses on “spillover” between intracellular signaling cascades
(Schwartz and Ginsberg, 2002). Second, the experiments
elucidate a previously unrecognized, Src-dependent signal-
ing pathway linking integrins, at least  3 1, with expression
of the SLUG family of transcription factors, key elements in
epithelial–mesenchymal development. And finally, the data
reveal a mechanistic connection between  3 1, uPAR, and
E-cadherin that may be pertinent to the observation that
uPAR and  3 1 levels are commonly enhanced and E-cad-
herin function suppressed in invasive human carcinomas.
These observations were empowered by the reported crystal
structure of  v 3, the crystal revealing the presence of a
 -propeller structure at the NH2-terminal region of the  
chain and its relationship to the I-like domain of the inte-
grin   chain (Fig. 1). This allowed selection of point mu-
tants of known location in the assembled integrin to probe
for distinct functions in different regions of the   chain pro-
peller. Our data indicate that this is the case. Matrix engage-
ment by  3 1 leads to the expected transient wave of FAK
activation, likely reflecting transient Src activation, and sup-
ports formation of stable E-cadherin connections, whereas
engagement of uPAR by  3 1 leads to a low but sustained
level of Src activation with eventual loss of cell–cell borders
and frank mesenchymal transition as reflected by up-regula-
tion of SLUG. Single amino acid mutations in  3 1 that
abrogate effective laminin-5 or uPAR engagement, or both,
block Src activation and its downstream consequences.
A possible caveat to these findings is that while uPAR ex-
pression in kidney epithelial cells regulates E-cadherin func-
tion in an integrin-specific manner, the levels of uPAR ex-
pression in this experimental system are high and could be
judged as nonphysiological. There is only a very low level of
endogenous mouse uPAR, as judged by immunoblotting, in
R10 cells (unpublished data). However, TGF 1 and other
growth factors implicated in tumor progression induce ex-
pression of uPAR in these cells. We have recently also ob-
served that TGF 1, known to promote dissolution of cell–
cell contacts and mesenchymal transition of kidney epithe-
lial cells, promotes dissociation of R10 cells in culture and
does so in an  3 1-dependent manner. Cells bearing the
H245A mutation do not lose stable E-cadherin junctions
in response to TGF 1 (unpublished data). Whether the
TGF 1 response is critically dependent on uPAR interact-
ing with  3 1 is under study. In any case, these findings in-
dicate that the mechanism linking  3 1 and E-cadherin
demonstrated here may also apply to epithelial cells respond-
ing to physiological stimulation accompanied by enhanced
uPAR expression and altered integrin function.
An important unanswered question is why Src activation
appears sustained upon uPAR engagement, whereas Src acti-
vation is transient after matrix attachment. Classical ligand-
induced integrin signaling is thought to lead to Src activa-
tion by altered conformation of the integrin cytoplasmic
tails and the clustering of integrins. The latter leads to the
concentration and cross-activation of signaling molecules,
including Src kinases, at the site of attachment (Schwartz
and Ginsberg, 2002). Tyrosine phosphatases, such as SHP-1,
rapidly accumulate at attachment sites and limit or reverse
protein phosphorylation (Rock et al., 1997). Engagement of
uPAR by  3 1 could be expected to be different in at least
two respects. There is little evidence to indicate clustering of
integrins by uPAR, at least when cells are plated on laminin-5
or fibronectin. This alone may alter the accumulation of ki-
nases and phosphatases at the site of integrin engagement.
Second, as a cis-acting integrin ligand, this glycosylphosphor-
ylinositol (GPI)-anchored membrane protein could be ex-
pected to bring its own set of associated membrane proteins
to the site of integrin interaction. Because uPAR associates
with lipid rafts, containing an array of signaling molecules
(Sargiacomo et al., 1993), we presume that the juxtaposition
of rafts and integrins leads to the distinct signaling patternsT
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and observed downstream consequences. This speculation is
supported by the pattern of enhanced tyrosine-phosphory-
lated proteins observed in R10/U cells. Whereas classical
downstream targets of integrin signals, such as p130CAS
and FAK, did not show sustained phosphorylation, the raft-
localized protein caveolin-1 did (Fig. 6 C). Tyrosine-phos-
phorylated caveolin-1 has been reported to bind the SH2
domain of the adaptor protein Grb7, implying that this ca-
veolin-1 phosphorylation itself could be a mediator of inte-
grin cross-talk (Lee et al., 2000). The fact that DnSrc–GFP,
which alters association of Src with its binding partners,
causes reversion to a clustered phenotype (Fig. 7 C) further
highlights the importance of Src localization. Exactly how
raft components might regulate Src kinase activity in an in-
tegrin-specific manner, and vice versa, remains an important
goal of future studies.
The observation that uPAR expression in epithelial cells
can regulate E-cadherin expression and function has not
been previously recognized. However, the capacity of
uPAR to influence E-cadherin function specifically through
 3 1 is not a complete surprise. This integrin localizes
closely with adherens junctions as well as with focal adhe-
sion sites (Wang et al., 1999). Indeed plating epithelial
cells on laminin-5 reportedly promotes E-cadherin–depen-
dent cell–cell adhesion (Dogic et al., 1998), consistent
with our observations (Fig. 3 B). The expression of uPAR
on the other hand has been linked to enhanced migratory
capacity of epithelial cells both in vitro and in vivo (Os-
sowski and Aguirre-Ghiso, 2000). Migration of epithelial
cells depends on both the disruption of cell–cell contacts
and reversible matrix engagement. Our observations shed
further light on how this occurs. Sustained expression of
uPAR led to loss of cell–cell clustering and markedly in-
creased, integrin-dependent motility (Fig. 3 C; Videos 1
and 2, available at http://www.jcb.org/cgi/content/full/
jcb.200304065/DC1). This was associated with decreases
in E-cadherin and  -catenin, the latter being a key compo-
nent of both adherens junctions and desmosomes (Kofron
et al., 2002), and was dependent on sustained Src-kinase
activation. What is the connection between activated Src
and altered expression of E-cadherin and  -catenin? Over-
expression of active Src kinases in either colon carcinoma
cells or keratinocytes has been reported to phosphorylate
components of the adherens junction complex, leading to
its dissolution and a redistribution of E-cadherin similar to
our observations (Fig. 5 A) (Owens et al., 2000; Avizienyte
et al., 2002). However, in contrast to these prior transfec-
tion approaches, which lead to high levels of active Src, the
level of sustained Src activation as a consequence of  3 1–
uPAR engagement appears much lower with no evident
change in the phosphorylation states of many of the known
Src substrates (Fig. 6 C). Instead, our data point to a dif-
ferent mechanism for loss of cell–cell borders, up-regula-
tion of SLUG. Expression of SLUG strictly correlated with
the phenotype of the kidney epithelial cells with elevated
SLUG in dispersed R10/U cells and falling SLUG levels af-
ter inhibition of either Src kinase or proper Src localization
(DnSrc–GFP) in parallel with reversion to an epithelial
phenotype (Fig. 6 A and Fig. 7 C). In addition, uPAR had
no effect on SLUG levels in H245A mutant cells, which
also failed to scatter with uPAR expression or alter cad-
herin or catenin levels. Although we cannot be sure that
the observed changes in SLUG levels alone cause reversion
to epithelial levels of E-cadherin and  -catenin and an epi-
thelial phenotype, these observations are consonant with
prior observations in several other cell systems that SLUG
regulates cadherin and catenin transcription and cell–cell
contact (Vallin et al., 2001; Bolos et al., 2003). To our
knowledge, these are the first data directly linking integrin
function with SLUG levels and further suggest that a spe-
cific integrin,  3 1, and how it is engaged by ligands, is an
important determinant of SLUG expression. How low lev-
els of active Src ultimately lead to SLUG transcription re-
mains to be defined.
High levels of SLUG repress E-cadherin promoter func-
tion, and levels of SLUG correlate inversely with E-cadherin
levels in various breast cancer cell lines (Hajra et al., 2002).
Although we cannot predict to what extent in human tu-
mors uPAR expression promotes SLUG expression with its
consequent negative effects on cadherin function, many
carcinomas exhibit both up-regulated uPAR and SLUG
and suppressed E-cadherin protein levels. Up-regulation of
uPAR and down-regulation of E-cadherin are both consid-
ered risk factors for tumor progression and poor prognosis.
Our data raise the possibility that one explanation for why
both observations are commonly found in more invasive tu-
mors is that they are mechanistically linked.
Materials and methods
Reagents
Full-length cDNAs for wt and G163A mutant human  3 in PBJ vector were
from Y. Takada (Scripps Research Institute, La Jolla, CA). Dominant-nega-
tive Src–GFP cDNA encoding Src 1–251 was a gift from P.L. Schwartzberg
(National Human Genome Research Institute, Bethesda, MD). Purified
laminin-5 was a gift from J.C. Jones (Northwestern University Medical
School, Chicago, IL). Anti- 3 antibody (P1B5) was purchased from Chemi-
con. Polyclonal anti- 3 (D23) and monoclonal anti-CD151 (5C11) were
provided by M.E. Hemler (Dana Farber Cancer Institute, Boston, MA).
Anti-uPAR antibody (R2) was a gift from G. Hoyer-Hansen (Finsen Lab,
Copenhagen, Denmark). Inhibitor to Src family tyrosine kinases PP2 and
its structurally inert isomer PP3 were from Calbiochem. Anticortactin
(4F11), antiphosphotyrosine (4G10), and Src assay kit were from Upstate
Biotechnology. Anti–phospho-FAK (Y397) and FAK mAbs, antiphosphoty-
rosine pAb, anti-p130Cas mAb, and anticaveolin pAb were from Trans-
duction Laboratories. Polyclonal antibodies to cortactin and p130Cas were
purchased from Santa Cruz Biotechnology, Inc. Anti– -catenin, anti–
 -catenin, and anti–E-cadherin mAbs (Transduction Laboratories) were
used for immunoblotting. For staining, rat anti–E-cadherin antibody (Zy-
med Laboratories) was used. Peptides  325 (PRHRHMGAVFLLSQEAG),
sc 325 (HQLPGAHRGVEARFSML), and  325HA (PRHRAMGAVFLL-
SQEAG) or  325RA (PRHAHMGAVFLLSQEAG) were synthesized at Uni-
versity of California San Francisco Biomolecular Resources Center and pu-
rified by HPLC.
Site-directed mutagenesis and cDNA cloning
PCR primers used for the H245A mutant were as follows: HP2, 5 -CGCGC-
CCATGGCTCGGTGCC-3 , and HP3, 5 -GGCACCGAGCCATGGGCGCG-
3 . The common outside primers were P1, 5 -TACCTGCTCCTGGCTGGT-
3 , and P4, 5 -ACAGGCTTCCCACTAGAAGGTCTG-3 . Purified PCR prod-
ucts were cut with SacI to replace the wt sequence in PBJ- 3. The mutant
 3 insert was then transferred to pCDNA3.1 for expression. All constructs
were confirmed by DNA sequencing before expression.
Cells and cell culture
Kidney epithelial cell line from  3 integrin–null (B12) and wild-type hu-
man  3–reconstituted B12 cells (R10) were prepared as previously de-
scribed (Wang et al., 1999). B12 cells were cultured in DME supplementedT
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with 10% FBS (Hyclone). R10 and mutant  3 (H245A, R244A, and
G163A) transfected cells were cultured in DME supplemented with 50  g/
ml of zeocin (Invitrogen). B12/U was grown in DME with 100  g/ml of hy-
gromycin B (Invitrogen). All the uPAR-cotransfected cells were cultured in
DME with both zeocin and hygromycin.
Flow cytometry
B12 cells and stable clones expressing wt or mutant  3 were stained with
primary antibody to integrin  3 (P1B5) and secondary FITC-conjugated
anti–mouse IgG (Sigma-Aldrich) and analyzed on a flow cytometer (FACS-
Caliber
®; BD Biosciences). uPAR-transfected cells were stained with a pri-
mary antibody to uPAR (R2).
Adhesion assay
The cell adhesion assay was performed as previously described (Wei et al.,
2001). In brief, cells were seeded on a laminin-5–coated plate and incu-
bated for 1 h at 37 C. After washing, attached cells were fixed and stained
with Giemsa. The data were quantified by measuring absorbance at a
wavelength of 550 nm.
Peptide binding assay
Human recombinant suPAR, a gift of G. Deng (Berlex Laboratories, Rich-
mond, CA), was biotinylated at 0.25 mg/ml. The binding of biotinylated
suPAR to peptide  325 was performed as previously described (Simon et
al., 2000). In brief, microtiter plates were coated with  325 (100  g/ml)
and incubated with biotinylated suPAR (50 nM)     325, sc 325, or
 325HA (1–50  M). After washing, avidin peroxidase was added, and
bound suPAR was quantified. Relative binding was calculated as the ratio
of binding in the presence of peptide to binding in the absence of peptide.
Immunofluorescence microscopy
Cells plated on chambered slides were fixed in 3.7% paraformaldehyde,
permeabilized with 0.5% Nonidet P-40, and blocked with 10% horse se-
rum and 1% BSA in PBS. The slides were stained with primary anti–E-cad-
herin antibody and FITC-conjugated secondary anti–rat IgG antibody (Lab
Tek). Slides were incubated with DAPI (Molecular Probes) before mount-
ing in Prolong (Molecular Probes).
Immunoprecipitation and immunoblotting
Cells expressing uPAR were lysed in Triton lysis buffer (50 mM Hepes, pH
7.5, 150 mM NaCl, 1% Triton X-100) supplemented with protease inhibi-
tors and 1 mM phenylmethylsulfonyl fluoride. Lysates were immunopre-
cipitated with antibody to uPAR (R2), and the immunoprecipitates were
blotted for  3 or uPAR using rabbit polyclonal antibodies. Ultracentrif-
ugation of lysates at 100,000 g had no effect on the amounts of subse-
quently recovered integrin and uPAR in the coimmunoprecipitations (Fig.
S3, available at http://www.jcb.org/cgi/content/full/jcb.200304065/DC1).
When precipitating phosphorylated proteins, RIPA buffer (50 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1% deoxycholate, 0.1% SDS, 1% Triton
X-100) was supplemented with additional 1 mM sodium vanadate, 10 mM
sodium fluoride, and 2 mM EDTA. In some cases, cells were extracted
with CSK buffer (50 mM NaCl, 10 mM Pipes, pH 6.8, 3 mM MgCl2, 0.5%
Triton X-100, 300 mM sucrose, supplemented with protease inhibitors and
1 mM PMSF) for 20 min at 4 C. The Triton X-100–insoluble fraction and
the whole cell lysate were blotted for E-cadherin,  -catenin,  -catenin,
 -actin, phospho-FAK, or total FAK.
Src kinase activity
Src family kinases were immunoprecipitated with anti–pan-Src antibody
(Src2), and the activity was quantified by incorporation of [ -
32P]ATP (10
 Ci; PerkinElmer) into a Src substrate peptide (Upstate Biotechnology) ac-
cording to the manufacturer’s instructions. Src kinase activity was ex-
pressed as pmol phosphate incorporated into the substrate peptide/min.
Taqman real-time PCR
Verification of transcript quantity in several selected cDNAs was per-
formed using Taqman real-time PCR. The primer pairs and probe for each
cDNA were designed using Primer Express software (Applied Biosystems).
The quantification was performed using the standard protocol of ABI
PRISM 7700 (Applied Biosystems).
Time-lapse microscopy
Cells were maintained in a heated chamber with 5% CO2 at 37 C on the
microscope stage. Cell motility analyses were performed using low (10 )
magnification time-lapse microscopy of random fields of cells over 18 h
(one frame/10 min). Cells were filmed over the same times after plating to
eliminate nonspecific differences. Cell tracking of each cell line was ana-
lyzed using SimplePCI software (Compix, Inc.).
Online supplemental material
The supplemental material (Videos 1 and 2 and Figs. S1–S3) is available at
http://www.jcb.org/cgi/content/full/jcb.200304065/DC1. Videos 1 and 2
show morphology and motility of R10/U and H245A/U cells over an 18-h
period by time-lapse microscopy. Frames were captured every 10 min as
indicated in the figure legends. Fig. S1 shows uPAR and integrin  3 coim-
munoprecipitates after ultracentrifugation. R244A and G163A mutations
disrupt coimmunoprecipitation of uPAR and integrin  3 (Fig. S2) and do
not change epithelial phenotype by uPAR expression (Fig. S3).
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